Reply to: "Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?"
Ann Surg Oncol
.
2021 Dec;28(Suppl 3):777-778.
doi: 10.1245/s10434-021-10073-3.
Epub 2021 May 7.
Authors
Patrick J McCormick
1
2
,
Melissa Assel
3
,
Kimberly J Van Zee
4
5
,
Andrew J Vickers
6
7
,
Jonas A Nelson
5
8
,
Monica Morrow
4
5
,
Hanae K Tokita
9
,
Brett A Simon
9
10
11
,
Rebecca S Twersky
9
10
Affiliations
1
Departments of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[email protected]
.
2
Departments of Anesthesiology, Weill Cornell Medicine, New York, NY, USA.
[email protected]
.
3
Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
4
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
5
Departments of Surgery, Weill Cornell Medicine, New York, NY, USA.
6
Departments of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
7
Departments of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
8
Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
9
Departments of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
10
Departments of Anesthesiology, Weill Cornell Medicine, New York, NY, USA.
11
Departments of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
PMID:
33961172
DOI:
10.1245/s10434-021-10073-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal
Breast Neoplasms* / surgery
Female
Humans
Ketorolac*
Mastectomy
Reoperation
Substances
Anti-Inflammatory Agents, Non-Steroidal
Ketorolac